These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

771 related items for PubMed ID: 29859132

  • 1. A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated study.
    Kalimuddin S, Chan YFZ, Phillips R, Ong SP, Archuleta S, Lye DC, Tan TT, Low JGH.
    Trials; 2018 Jun 01; 19(1):305. PubMed ID: 29859132
    [Abstract] [Full Text] [Related]

  • 2. Vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations: study protocol for a phase IIB randomized controlled trial.
    Kalimuddin S, Phillips R, Gandhi M, de Souza NN, Low JG, Archuleta S, Lye D, Tan TT.
    Trials; 2014 Jun 19; 15():233. PubMed ID: 24943129
    [Abstract] [Full Text] [Related]

  • 3. Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study.
    Moore CL, Osaki-Kiyan P, Haque NZ, Perri MB, Donabedian S, Zervos MJ.
    Clin Infect Dis; 2012 Jan 01; 54(1):51-8. PubMed ID: 22109947
    [Abstract] [Full Text] [Related]

  • 4. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    Claeys KC, Zasowski EJ, Casapao AM, Lagnf AM, Nagel JL, Nguyen CT, Hallesy JA, Compton MT, Kaye KS, Levine DP, Davis SL, Rybak MJ.
    Antimicrob Agents Chemother; 2016 Oct 01; 60(10):5841-8. PubMed ID: 27431221
    [Abstract] [Full Text] [Related]

  • 5. Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation.
    Moise PA, Culshaw DL, Wong-Beringer A, Bensman J, Lamp KC, Smith WJ, Bauer K, Goff DA, Adamson R, Leuthner K, Virata MD, McKinnell JA, Chaudhry SB, Eskandarian R, Lodise T, Reyes K, Zervos MJ.
    Clin Ther; 2016 Jan 01; 38(1):16-30. PubMed ID: 26585355
    [Abstract] [Full Text] [Related]

  • 6. Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study.
    Murray KP, Zhao JJ, Davis SL, Kullar R, Kaye KS, Lephart P, Rybak MJ.
    Clin Infect Dis; 2013 Jun 01; 56(11):1562-9. PubMed ID: 23449272
    [Abstract] [Full Text] [Related]

  • 7. Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.
    Arshad S, Huang V, Hartman P, Perri MB, Moreno D, Zervos MJ.
    Int J Infect Dis; 2017 Apr 01; 57():27-31. PubMed ID: 28131729
    [Abstract] [Full Text] [Related]

  • 8. Implementation of an antimicrobial stewardship pathway with daptomycin for optimal treatment of methicillin-resistant Staphylococcus aureus bacteremia.
    Kullar R, Davis SL, Kaye KS, Levine DP, Pogue JM, Rybak MJ.
    Pharmacotherapy; 2013 Jan 01; 33(1):3-10. PubMed ID: 23307539
    [Abstract] [Full Text] [Related]

  • 9. Impact of Molecular Epidemiology and Reduced Susceptibility to Glycopeptides and Daptomycin on Outcomes of Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Lee HY, Chen CL, Liu SY, Yan YS, Chang CJ, Chiu CH.
    PLoS One; 2015 Jan 01; 10(8):e0136171. PubMed ID: 26295150
    [Abstract] [Full Text] [Related]

  • 10. Vancomycin or Daptomycin Plus a β-Lactam Versus Vancomycin or Daptomycin Alone for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: A Systematic Review and Meta-Analysis.
    Yi YH, Wang JL, Yin WJ, Xu WH.
    Microb Drug Resist; 2021 Aug 01; 27(8):1044-1056. PubMed ID: 33728980
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro identification of underutilized β-lactam combinations against methicillin-resistant Staphylococcus aureus bacteremia isolates.
    Davis KP, McDermott LA, Snydman DR, Aldridge BB.
    Microbiol Spectr; 2024 Aug 06; 12(8):e0097624. PubMed ID: 38916355
    [Abstract] [Full Text] [Related]

  • 17. Comparative effectiveness of daptomycin versus vancomycin among patients with methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: A systematic literature review and meta-analysis.
    Adamu Y, Puig-Asensio M, Dabo B, Schweizer ML.
    PLoS One; 2024 Aug 06; 19(2):e0293423. PubMed ID: 38381737
    [Abstract] [Full Text] [Related]

  • 18. Vancomycin and daptomycin minimum inhibitory concentrations as a predictor of outcome of methicillin-resistant Staphylococcus aureus bacteraemia.
    Ruiz J, Ramirez P, Concha P, Salavert-Lletí M, Villarreal E, Gordon M, Frasquet J, Castellanos-Ortega Á.
    J Glob Antimicrob Resist; 2018 Sep 06; 14():141-144. PubMed ID: 29601996
    [Abstract] [Full Text] [Related]

  • 19. CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.
    Tong SY, Nelson J, Paterson DL, Fowler VG, Howden BP, Cheng AC, Chatfield M, Lipman J, Van Hal S, O'Sullivan M, Robinson JO, Yahav D, Lye D, Davis JS, CAMERA2 study group and the Australasian Society for Infectious Diseases Clinical Research Network.
    Trials; 2016 Mar 31; 17():170. PubMed ID: 27029920
    [Abstract] [Full Text] [Related]

  • 20. Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial.
    Cheng MP, Lawandi A, Butler-Laporte G, Paquette K, Lee TC.
    Trials; 2018 May 29; 19(1):297. PubMed ID: 29843781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.